Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, June 13, 2024 | Back issues
Courthouse News Service Courthouse News Service

Cancer Drug Antitrust Claims

The Second Circuit ruled that a Russian pharmaceutical firm’s antitrust claims were barred by the Foreign Trade Antitrust Improvements Act, because the alleged price-fixing and kickbacks aimed at thwarting the firm’s U.S. launch of cancer-treatment drugs occurred in Russia. 

NEW YORK – The Second Circuit ruled that a Russian pharmaceutical firm’s antitrust claims were barred by the Foreign Trade Antitrust Improvements Act, because the alleged price-fixing and kickbacks aimed at thwarting the firm’s U.S. launch of cancer-treatment drugs occurred in Russia. 

Categories / Appeals, Business

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...